"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

This study found a steep decline in cervical cancer mortality among US women younger than 25 years between 2016 and 2021.

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.

Cervical cancer deaths among women under 25 have significantly decreased, with researchers at the MUSC Hollings Cancer Center ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

Human Papilloma Virus Consultant for the Clinton Health Access Initiatives (CHAI), Mr. Akpan Etop, revealed that 380,671 ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher ...

Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vaccination ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when limited to those at higher risk for acquiring HPV ...

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both ...

Vaccination against HPV can reduce rates of cervical cancer by up to 90 per cent. In countries where HPV vaccination rates ...